Endo Pharmaceuticals Buys HealthTronics, Bringing Devices Into Urology Biz

In a push to diversify, Endo Pharmaceuticals announced May 5 that it is buying HealthTronics, a urology device and services company, for $223 million in cash, or $4.85 a share, plus an assumption of $35 million in debt